Physician profile
Deji O Okuboye
NPI 1528196227
$76,578.39
in general payments reported to CMS, 2019-2025
76 companies · $7,544 in 2025
The $7,544 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,148 · 2021: $18K · 2022: $3,412 · 2023: $13K · 2024: $14K · 2025: $7,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $12K · Travel and Lodging: $1,979 · Education: $47.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,800.00 |
| Food and Beverage | $12,173.39 |
| Travel and Lodging | $1,979.44 |
| Education | $47.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13,049.12 | 2019-2025 | Otezla, Otezla, Repatha |
| Abbvie INC. | $10,882.48 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $8,854.89 | 2020-2021 | |
| Valeritas, INC. | $6,604.07 | 2019 | |
| Dexcom, INC. | $5,874.00 | 2019-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $4,769.08 | 2019-2025 | |
| Zealand Pharma US, INC. | $3,827.78 | 2020-2022 | |
| Mannkind Corporation | $3,161.96 | 2022-2025 | V-Go, Afrezza |
| Astrazeneca Pharmaceuticals LP | $2,740.64 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,650.24 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $1,632.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Otsuka America Pharmaceutical, INC. | $1,181.57 | 2019-2025 | Rexulti, Abilify Maintena |
| Bayer Healthcare Pharmaceuticals INC. | $1,174.69 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $1,120.83 | 2019-2023 | |
| Novo Nordisk INC | $1,059.39 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $582.68 | 2019-2025 | Jardiance, Synjardy, Stiolto Respimat |
| Axsome Therapeutics, INC. | $566.69 | 2022-2025 | Auvelity |
| Medtronic, INC. | $551.66 | 2021-2025 | Kyphon Express II Kyphopak Tray, Interstim, Endurant Iis |
| Allergan, INC. | $469.62 | 2019-2021 | |
| Amarin Pharma, INC. | $459.09 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $441.49 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Bausch Health US, LLC | $356.74 | 2019-2025 | Wellbutrin, Aplenzin |
| Sanofi US Services INC. | $350.00 | 2021 | |
| Gilead Sciences, INC. | $349.95 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $304.92 | 2019-2025 | Glassia, Trintellix |
| Endo Pharmaceuticals INC. | $300.42 | 2020-2024 | Aveed, Xiaflex |
| Teva Pharmaceuticals USA, INC. | $268.82 | 2019-2025 | Ajovy |
| Astellas Pharma US INC | $211.32 | 2021-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $193.76 | 2019-2025 | |
| Mylan Specialty L.P. | $189.87 | 2019-2024 | Yupelri |
| Abbott Laboratories | $181.16 | 2020-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $177.61 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $177.10 | 2024-2025 | Purified Cortrophin Gel |
| Biohaven Pharmaceutical Holding Company LTD. | $170.00 | 2022 | |
| Merz North America, INC. | $169.43 | 2019-2025 | |
| Corcept Therapeutics | $158.22 | 2020-2025 | Korlym |
| Esperion Therapeutics, INC. | $155.47 | 2020 | |
| Corium, LLC | $134.97 | 2022-2024 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.07 | 2023-2025 | Caplyta |
| Exact Sciences Corporation | $129.78 | 2023-2025 | Cologuard Collection Kit |
| Impel Pharmaceuticals INC. | $128.98 | 2023 | Trudhesa |
| Phathom Pharmaceuticals, INC. | $120.21 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $108.09 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $105.95 | 2024-2025 | Ingrezza |
| Daiichi Sankyo INC. | $95.95 | 2021-2022 | |
| Lundbeck LLC | $94.67 | 2022-2025 | Vyepti, Rexulti |
| Xeris Pharmaceuticals, INC. | $94.59 | 2022-2024 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.84 | 2019-2024 | Xifaxan |
| Verona Pharma, INC. | $84.07 | 2025 | Ohtuvayre |
| Nestle Healthcare Nutrition INC. | $74.63 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $72.70 | 2023-2025 | Gemtesa |
| Tris Pharma INC | $61.05 | 2019-2025 | Dyanavel Xr |
| Genzyme Corporation | $60.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $56.97 | 2019 | |
| Viatris Specialty LLC | $47.48 | 2025 | Yupelri |
| Organon LLC | $42.13 | 2021-2024 | Nexplanon |
| Endo USA, INC. | $41.76 | 2024-2025 | Aveed, Xiaflex |
| Cranial Technologies, INC | $41.52 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $41.05 | 2022-2023 | Quviviq |
| Cequr Corporation | $40.71 | 2023-2024 | Cequr Simplicity |
| Impel Pharmaceuticals LLC | $35.39 | 2025 | Trudhesa |
| Genentech USA, INC. | $25.32 | 2020-2021 | |
| Inari Medical, INC. | $25.16 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sequel Med Tech, LLC | $22.46 | 2025 | Twiist |
| Vanda Pharmaceuticals INC. | $21.99 | 2025 | Fanapt |
| Renalytix Ai, INC. | $21.41 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Aimmune Therapeutics, INC. | $19.77 | 2024 | |
| Beta Bionics, INC. | $19.00 | 2024 | Ilet Bionic Pancreas |
| Medtronic Minimed, INC. | $17.34 | 2020 | |
| Insulet Corporation | $16.89 | 2021 | |
| Dermira, INC. | $16.55 | 2020 | |
| Irhythm Technologies, INC. | $15.48 | 2024 | Zio Monitor, Zio Xt Patch |
| Kaleo, INC. | $15.01 | 2021 | |
| Mdd US Operations, LLC | $12.36 | 2020 | |
| Shire North American Group INC | $12.04 | 2019 | |
| Senseonics, Incorporated | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deji Okuboye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.